FILGRASTIM
filgrastim 120 microgram/0.2 mL injection, 10 x 0.2 mL syringes
FILGRASTIM (5830W)
5830W
Body System:
Manner of administration:Injection
Restriction 8674
Indication: Chemotherapy-induced neutropenia
Restriction 8667
Indication: Chemotherapy-induced neutropenia
Restriction 8672
Indication: Mobilisation of peripheral blood progenitor cells
Restriction 8668
Indication: Mobilisation of peripheral blood progenitor cells
Restriction 8671
Indication: Assisting bone marrow transplantation
Restriction 8696
Indication: Assisting autologous peripheral blood progenitor cell transplantation
Restriction 8669
Indication: Severe congenital neutropenia
Restriction 8670
Indication: Severe chronic neutropenia
Restriction 8673
Indication: Chronic cyclical neutropenia
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 20 | # of repeats: 11 | DPMQ: $266.46 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Nivestim | |||||